Osteoarthritis is characterised by progressive synovial joint damage resulting in structural changes, pain and reduced function.
It is the most common form of arthritis. Individuals are affected differently, but pain and functional limitation can significantly affect quality of life.
The hands, knees and hips are commonly affected by this condition that leads to cartilage loss and subsequent remodelling of bone. Management includes addressing modifiable risk factors, analgesia and joint replacement surgery.
It is estimated that 8.75 million people aged 45 or older in the UK have sought treatment for osteoarthritis.
In England, 4.11 million aged 45 or older suffer with knee osteoarthritis, 2.46 million suffer with hip osteoarthritis.
Prevalence is higher in women (particularly disease affecting hands and knees). Women are more likely to require surgery and account for 60% of hip and knee replacements in the UK.
Osteoarthritis is a pathology of the entire unit of a synovial joint.
Though traditionally taught as a pathology of articular cartilage, our understanding of osteoarthritis has changed. We are now aware the pathology affects the whole unit of the synovial joint including the synovial fluid and adjacent bone.
In addition, osteoarthritis has normally been referred to as a non-inflammatory arthritis, however we now know inflammatory mediators and processes play a key role in the pathogenesis. It appears inflammatory cytokines interrupt normal repair of cartilage damage.
As cartilage is lost, the joint space narrows, with areas of highest load affected the most. Bone on bone interaction may occur causing large amounts of stress and reactive changes with subchondral sclerosis (via a process called eburnation) seen on x-ray. Cystic degeneration may occur resulting in subchondral cysts.
Osteoarthritis is relatively uncommon before the age of 45, obesity is a significant modifiable risk factor.
Osteoarthritis is characterised by activity related joint pain. Three common patterns are nodal, knee and hip osteoarthritis.
The most commonly affected joint is the first carpometacarpal (CMC, base of the thumb). The dorsal interphalangeal (DIP) joints and proximal interphalangeal (PIP) joints are often involved. The DIPs are more frequently affected than the PIPs.
Disease is classically described as bilateral and occurring in post-menopausal women.
Progressive disease may result in several characteristic appearances:
4.11 million people aged over 45 have knee osteoarthritis in England. It is commonly bilateral and often seen with nodal osteoarthritis. Features include:
Obesity is a significant risk factor, with the medial compartment (normally) far worse affected that the lateral. This can result in a varus deformity becoming apparent. Tricompartmental knee osteoarthritis refers to that affecting the medial, lateral and patella-femoral compartments.
2.46 million people aged over 45 have hip osteoarthritis in England. Classical features include:
X-ray is the most commonly used imaging modality in the assessment of osteoarthritis.
Simple, quick and cheap. X-ray will almost always be the first imaging modality obtained if visualisation of the joint is indicated. Classical findings include:
However, clinicians must remember that radiographic findings are poorly linked to the patients symptomatic experience. Relatively mild x-ray changes can be experienced as severe and disabling pain.
Both MRI and CT offer excellent views of the joint. MRI is generally preferred, particularly in the knee when soft tissue injuries of the ACL, PCL, MCL, LCL and menisci are of great interest.
USS is not typically used in the investigation of osteoarthritis. It may however be used when excluding differentials or to guide interventions (e.g. steroid injection)
The diagnosis of osteoarthritis is largely clinical based on the presence of characteristic symptoms.
NICE advise a clinical diagnosis can be made when a patient:
It is important to consider alternative diagnoses, in particular inflammatory arthropathy, septic arthritis and malignancy.
This of course is not to say osteoarthritis can’t develop before the age of 45. However, as it is less common a higher degree of suspicion is needed to exclude alternative diagnoses and imaging of the joint is likely needed.
The assessment of patients with osteoarthritis should be holistic, identifying how the disease affects each individual uniquely.
Everyone is impacted differently by osteoarthritis. To effectively help and manage a patients condition, a full understanding of their disease and its results is needed.
NICE advise discussing the following domains:
Exercise and appropriate weight loss may result in marked improvement of symptoms.
The diagnosis of osteoarthritis should be explained to the patient, as well as the various management options. Make them aware of support groups/ charities such as Versus Arthritis.
When appropriate patients should be counselled on the benefits of weight loss, on both their symptoms and the progression of their disease.
The goal is to help weight loss (when needed), increase muscle strength, flexibility and improve aerobic fitness.
For patients with knee and hip osteoarthritis, low impact exercises are often advised. Swimming and static bike cycling are excellent options.
Referral to physiotherapy is the standard - they will be able to explain different exercises that may help with their symptoms and give them a tailored programme to follow.
Patients may find transcutaneous electrical nerve stimulation (TENS) offers significant pain relief and helps to reduce reliance on oral analgesia.
Assessment of foot wear, with advice of appropriate choices should form part of the advice given to a patient. If there are abnormal biomechanics in the lower limb, adjuncts like insoles may be of use.
NICE advise against offering glucosamine, chondroitin and acupuncture.
Paracetamol, topical gels and opioid analgesia may be used to control pain.
Paracetamol is the safest oral option and often helps with symptoms. Topical NSAIDs and capsaicin (in particular for knee and hand osteoarthritis) can be used as an adjunct. Opioid analgesia, after considering the risks, can be offered.
The risks of long-term (or even short-term) NSAIDs are increasingly well understood, and are increased in older patients. These include peptic ulcer disease, upper GI bleeding and kidney injury.
If required NSAIDs use should be at the lowest dose appropriate, for the shortest duration needed, typically with PPI cover.
Steroid injections may offer marked improvement in symptoms when used as an adjunct to other therapies. The effects are often short lived and in many patients minimal. Risks include septic arthritis (very rare) and avascular necrosis.
NICE advise against hyaluronan injections (due to lack of evidence of efficacy), though some clinicians do use them, typically the patient must buy the medication privately.
In patients whose quality of life is impacted and non-surgical options are ineffective, joint replacement should be considered.
Knee arthroscopy is not routinely advised in the management of osteoarthritis. It may be indicated in those with a loose body and mechanical locking.
Osteoarthritis is the most common indication for primary hip (90%) and knee (98%) replacement. The indication for surgery is typically osteoarthritis substantiality impacting the patients quality of life that has not responded to conservative measures.
It is a common and safe operation, but all surgery has risks. Key complications include disclocation (hip replacement), limb length discrepancy, aseptic loosening, blood clots and prosthetic joint infection.
The operations are largely successful at reducing pain and improving mobility. Appropriate post-operative rehabilitation and physio is central to this success. On a survey published by Versus Arthritis after joint replacement 21.1% of knee and 16.6% of hip patients described moderate to severe pain. The figures for those without surgery was 94.6% and 93.9% respectively.
Have comments about these notes? Leave us feedback